Real-world safety and efficacy of trastuzumab-deruxtecan (T-DXd) in HER2-positive advanced breast cancer (ABC) elderly patients (pts): The TREX-Old retrospective registry

Non ancora tradotto Non ancora tradotto
Categoria Primary study
GiornaleESMO Open
Year 2023
Questo articolo non ha abstract
Epistemonikos ID: fdfaec237336ba4fce420ef174f9bdda67cd330c
First added on: Feb 16, 2025